标题
Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia
作者
关键词
-
出版物
International Journal of Endocrinology
Volume 2013, Issue -, Pages 1-7
出版商
Hindawi Limited
发表日期
2013-04-18
DOI
10.1155/2013/167138
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Screening for Osteoporosis in Men: A Systematic Review for an American College of Physicians Guideline
- (2013) Hau Liu et al. ANNALS OF INTERNAL MEDICINE
- Cigarette Smoking Among Persons With Schizophrenia or Bipolar Disorder in Routine Clinical Settings, 1999–2011
- (2013) Faith Dickerson et al. PSYCHIATRIC SERVICES
- Reducing all-cause mortality among patients with psychiatric disorders: a population-based study
- (2012) S. Kisely et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Osteoporosis and fracture risk in people with schizophrenia
- (2012) Taishiro Kishimoto et al. CURRENT OPINION IN PSYCHIATRY
- An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures
- (2012) Léon Nshimyumukiza et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gain
- (2011) Katherine J. Motyl et al. BONE
- Defining Ethnic and Racial Differences in Osteoporosis and Fragility Fractures
- (2011) Jane A. Cauley CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Risk of osteoporosis and fracture incidence in patients on antipsychotic medication
- (2011) Simon Matthew Graham et al. Expert Opinion On Drug Safety
- Bone Mineral Density and Osteoporosis Risk in Older Patients With Schizophrenia
- (2011) Do-Un Jung et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Functional –1149 G/T Polymorphism of the Prolactin Gene in Schizophrenia
- (2011) Janusz K. Rybakowski et al. NEUROPSYCHOBIOLOGY
- Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
- (2011) Joo-Cheol Shim et al. NEUROPSYCHOPHARMACOLOGY
- Positron Emission Tomography Measurement of Dopamine D2Receptor Occupancy in the Pituitary and Cerebral Cortex
- (2010) Ryosuke Arakawa et al. JOURNAL OF CLINICAL PSYCHIATRY
- Bone mass in schizophrenia and normal populations across different decades of life
- (2009) Jenn-Huei Renn et al. BMC MUSCULOSKELETAL DISORDERS
- Hyperprolactinemia-Related Adverse Events Associated with Antipsychotic Treatment in Children and Adolescents
- (2009) Jeanette M. Jerrell et al. JOURNAL OF ADOLESCENT HEALTH
- Evidence for direct effects of prolactin on human osteoblasts: Inhibition of cell growth and mineralization
- (2009) Dutmanee Seriwatanachai et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Antipsychotic Medication in Children and Adolescents: A Descriptive Review of the Effects on Prolactin Level and Associated Side Effects
- (2009) Yvette Roke et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Sex- and Age-Specific Incidence of Fractures in Mental Illness
- (2009) Kathryn M. Abel et al. JOURNAL OF CLINICAL PSYCHIATRY
- 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
- (2009) Jari Tiihonen et al. LANCET
- Antipsychotic use and the risk of hip/femur fracture: a population-based case–control study
- (2009) S. Pouwels et al. OSTEOPOROSIS INTERNATIONAL
- Anxiolytics and Sedatives and Risk of Fractures: Effects of Half-life
- (2008) Peter Vestergaard et al. CALCIFIED TISSUE INTERNATIONAL
- Ultrasound bone mass in schizophrenic patients on antipsychotic therapy
- (2008) Purificación Rey-Sánchez et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- A review of the association between antipsychotic use and hyperprolactinaemia
- (2008) Chris Bushe et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Antipsychotics and hyperprolactinaemia: Clinical recommendations
- (2008) Robert C Peveler et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Change in sexual dysfunction with aripiprazole: a switching or add-on study
- (2008) Amna Mir et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor κB ligand/osteoprotegerin ratio
- (2007) Dutmanee Seriwatanachai et al. BONE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started